Phospholipase A activity of adenylate cyclase toxin mediates translocation of its adenylate cyclase domain

Significance

Numerous bacterial toxins can cross cell membranes, penetrating the cytosol of their target cells, but to do so exploits cellular endocytosis or intracellular sorting machineries. Bordetella pertussis adenylate cyclase toxin (ACT) delivers its catalytic domain directly across the cell membrane by an unknown mechanism, and generates cAMP, which subverts the cell signaling. Here, we decipher the fundamentals of the molecular mechanism of ACT transport. We find that AC translocation and, consequently cytotoxicity, are determined by an intrinsic ACT–phospholipase A (PLA) activity, supporting a model in which in situ generation of nonlamellar lysophospholipids by ACT–PLA activity remodels the cell membrane, forming proteolipidic toroidal “holes” through which AC domain transfer may directly take place. PLA-based specific protein transport in cells is unprecedented.

Abstract

Adenylate cyclase toxin (ACT or CyaA) plays a crucial role in respiratory tract colonization and virulence of the whooping cough causative bacterium Bordetella pertussis. Secreted as soluble protein, it targets myeloid cells expressing the CD11b/CD18 integrin and on delivery of its N-terminal adenylate cyclase catalytic domain (AC domain) into the cytosol, generates uncontrolled toxic levels of cAMP that ablates bactericidal capacities of phagocytes. Our study deciphers the fundamentals of the heretofore poorly understood molecular mechanism by which the ACT enzyme domain directly crosses the host cell membrane. By combining molecular biology, biochemistry, and biophysics techniques, we discover that ACT has intrinsic phospholipase A (PLA) activity, and that such activity determines AC translocation. Moreover, we show that elimination of the ACT–PLA activity abrogates ACT toxicity in macrophages, particularly at toxin concentrations close to biological reality of bacterial infection. Our data support a molecular mechanism in which in situ generation of nonlamellar lysophospholipids by ACT–PLA activity into the cell membrane would form, likely in combination with membrane-interacting ACT segments, a proteolipidic toroidal pore through which AC domain transfer could directly take place. Regulation of ACT–PLA activity thus emerges as novel target for therapeutic control of the disease.